Vishal Bhalani, MD
Weiss urologist Vishal Bhalani, M.D., has recently been featured in the media as a medical expert. View the news segments below.
Vishal Bhalani, M.D., comments on the importance of discussing erectile dysfunction with your doctor in order to address underlying health issues, as seen on QualityHealth.com. Read the article.
- During a recent health interview on CBS, Dr. Bhalani discussed
the risks, signs and treatment options for prostate cancer, as well as
the importance of early detection. Watch Men and Prostate Cancer Risk, as seen on CBS Channel 2, for the full story.
Urologist, Weiss Memorial Hospital
Dr. Bhalani is board-certified in urology and serves as the chair of the Robotics Steering Committee at Weiss Memorial Hospital. He is also a member of the American Urological Association, North Central Section of AUA, and the Chicago Urological Society. He has published numerous journal articles on topics related to the treatment of prostate cancer, renal cell carcinoma and kidney stones. Dr. Bhalani also has improved the techniques of robotic and minimally invasive surgery, presenting his work at national and international conferences.
In addition to his devotion to advancing the field of urology, Dr. Bhalani is known for his humility and patient-friendly disposition. He strives to achieve excellent outcomes through effective communication so that patients understand their condition and treatment options.
“Patients are better served when technology is humanized,” he said.
Outside of his practice, Dr. Bhalani enjoys travel, basketball and advocating for stronger public health initiatives.
Weiss Memorial Hospital
4700 N. Marine Drive
Chicago, IL 60640
- Medical School: University of Miami, FL
- Internship: University of North Carolina, Chapel Hill, NC
- Residency: Northwestern University, Chicago, IL
Areas of Special Clinical Interests
- Urologic oncology
- Prostate cancer
- Robotics and minimally invasive surgery
- Erectile dysfunction
- Urethral reconstruction
- BPH and laser treatments
- Renal cell carcinoma
Telephone: (773) 564-5355
Fax: (773) 564-5362